TESS validation for benign and malignant extremity tumors
Not Applicable
- Conditions
- Health Condition 1: C498- Malignant neoplasm of overlappingsites of connective and soft tissue
- Registration Number
- CTRI/2021/06/034155
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age >18 years
2.treated surgically with curative intent for an extremity bone or soft tissue tumor (benign or malignant) with a minimum 3 months follow up
3.Ability to communicate in English/Hindi/Marathi.
4.Ability to give a valid written informed consent.
Exclusion Criteria
1.Patients with impaired or challenged communication or inability to complete the questionnaire without external help
2.Patients with unstable medical, oncologic or other emergencies
3.Patients being treated with palliative intent or best supportive care
Patients presenting with local or systemic recurrence
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.face validity, <br/ ><br>2.translation, <br/ ><br>3.concurrent validity, <br/ ><br>4.construct validity and <br/ ><br>5.reliability. <br/ ><br>6.Confirmatory factor analysis <br/ ><br>Timepoint: At baseline (minimum 3 month follow up from surgery) and repeated at 1 week
- Secondary Outcome Measures
Name Time Method validation of this score with the above detailed outcome measures is the only outcome of this studyTimepoint: 2 years